IHC assays revealed that phosphorylated MerTK was significantly reduced in tumor tissues from Z-138-xenograft models treated with 50 mg/kg UNC2250 and 75 mg/kg compared to that in the vehicle-treated group (Fig. 5c, d). The gene discussed is MERTK; the disease is neoplasm.